GTC
TNYA icon

Ghost Tree Capital’s Tenaya Therapeutics TNYA Stock Holding History

Ghost Tree Capital’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.9M Buy
1,500,000
+150,000
+11% +$423K 0.87% 40
2024
Q2 		$4.18M Buy
1,350,000
+575,000
+74% +$2.37M 1.31% 31
2024
Q1 		$4.05M Buy
+775,000
New +$3.71M 1.12% 30

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Ghost Tree Capital's TNYA Position: Q3 2024 in Review

Ghost Tree Capital increased its Tenaya Therapeutics (TNYA) stake by 11% in Q3 2024, buying an estimated $423K and bringing the position to 1,500,000 shares worth $2.9M. The position accounts for 0.87% of the portfolio, ranked #40.

Ghost Tree Capital first reported a position in TNYA in Q1 2024 and has held it in 3 quarters since. The position peaked at $4.18M in Q2 2024. 95 funds tracked by Wall St. Rank hold TNYA as of Q3 2024.

  • Ghost Tree Capital held 1,500,000 shares of Tenaya Therapeutics worth $2.9M as of Q3 2024.
  • Ghost Tree Capital bought 150,000 Tenaya Therapeutics shares in Q3 2024, an estimated $423K.
  • Tenaya Therapeutics made up 0.87% of Ghost Tree Capital's portfolio in Q3 2024, its #40 holding.
  • Ghost Tree Capital first reported a position in Tenaya Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Ghost Tree Capital's Tenaya Therapeutics position peaked at $4.18M in Q2 2024.
  • 95 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.